Japanese company Kobayashi Pharmaceutical is investigating 80 deaths possibly linked to its CholesteHelp supplement, highlighting lax supplement regulation in Japan.
The supplement reportedly contained puberulic acid, a highly toxic compound produced by mold, leading to health concerns and hospitalizations among consumers.
Quality control guidelines for health claim products in Japan, where Kobayashi Pharmaceutical is based, are seen as less stringent than regulations for prescription medications.
[
add
]
[
|
|
...
]